Antineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsBenzimidazoles
Dr. Michael E. Menefee, MD
NPI1760598601PAC ID1557306685
- Medicare services, 2024
- 328
- Medicare patients, 2024
- 58
- Part D claims, 2024
- 261
- Publications
- 14
- Clinical trials
- 1
- Practice address
- 1 Akron General Avenue, Akron, OH 44307
- Practice phone
- Call (330) 344-6000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Menefee's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Michael E. Menefee is a medical oncologist in Akron, Ohio
Dr. Menefee practices at Cleveland Clinic Akron General in Akron, Ohio, part of The Cleveland Clinic Foundation.
Dr. Menefee's NPI, 1760598601, was assigned on August 22, 2006. Dr. Menefee graduated from Meharry Medical College School of Medicine in 1999. Dr. Menefee holds Ohio license 35C.000929.
NPI and contact details
- NPI
- 1760598601NPI Registry (opens in a new tab)
- Medicare PAC ID
- 1557306685
- NPI enumeration date
- August 22, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (330) 344-6000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 53
- Medical school graduation
- 1999
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Michael E. Menefee practices at Cleveland Clinic Akron General in Akron, Ohio
Dr. Menefee's primary practice is Cleveland Clinic Akron General, at 1 Akron General Avenue, Akron, OH 44307 in Summit County. The practice phone is (330) 344-6000.
- Cleveland Clinic Akron General1 Akron General Avenue, Akron, OH 44307 · Summit CountyPhone(330) 344-6000
Source: Dmand AI Affiliation Data
Dr. Michael E. Menefee is affiliated with 5 sites of care and 1 medical group
Dr. Menefee's primary practice is Cleveland Clinic Akron General in Akron, Ohio, part of The Cleveland Clinic Foundation. Dr. Menefee is also affiliated with Cleveland Clinic Main Campus. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Menefee to 3 more hospitals, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Michael E. Menefee's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Menefee practices, 5 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Cleveland Clinic Akron General | Available with a free account |
| +4 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Menefee practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across The Cleveland Clinic Foundation and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Michael E. Menefee is one of 175 medical oncologists in Ohio
Medical oncology is Dr. Menefee's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Menefee is licensed in Ohio.
Specialties and state licenses
- Medical oncology, OhioPrimary
Medical oncologists near Dr. Menefee
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
175medical oncologists in Ohio
5medical oncologists in Akron
4medical oncologists at Cleveland Clinic Akron GeneralSources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Michael E. Menefee billed Medicare for 328 services in 2024
CMS data shows 328 Medicare services from Dr. Menefee across 5 procedure codes in 2024, for 58 Medicare patients. Medicare paid $14,039 for them.
Medicare services, 2024328
Medicare patients58
Paid by Medicare$14,039
Procedure codes5
Dr. Menefee's Medicare services by type, 2017 to 2024
- 2017
- 2024
- Other services
- 2017: 02024: 180
- Office and hospital visits
- 2017: 2712024: 14845%
- Drugs given in the office
- 2017: 8,6822024: 0100%
- Tests and treatments
- 2017: 1,0692024: 0100%
Where Dr. Menefee's Medicare services took place, 2024
- In an office15547%
- In a facility17353%
Dr. Menefee compared with the Ohio median for medical oncologists, 2024
- Dr. Menefee
- Ohio median
- Medicare services
- 328vs 338Close to median
- Medicare patients
- 58vs 13256% below
- Part D claims
- 134vs 19832% below
Medians across 168 medical oncologists in Ohio with Dmand AI profiles that report each measure.
Dr. Menefee's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Menefee?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Menefee and other medical oncologists in Ohio.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Michael E. Menefee treated 58 Medicare patients in 2024, average age 75
CMS counts 58 Medicare patients who saw Dr. Menefee in 2024. The largest group is 65 to 74, with 30 patients. 75% of them have high cholesterol, and 72% have high blood pressure. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Menefee's median patient age at 69, with 47% women.
Medicare patients, 202458
Average age75
Average risk score1.67
Dr. Menefee's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Menefee's Medicare patients by sex, 2024
- Women2645%
- Men3255%
Chronic conditions among Dr. Menefee's Medicare patients, 2024
- High cholesterol75%
- High blood pressure72%
- Cancer67%
- Anxiety40%
- Arthritis40%
- Diabetes38%
- Chronic kidney disease34%
- Atrial fibrillation31%
Share of Medicare patients with each condition. A patient can have several.
Dr. Menefee's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 69
Patient panel by sex, all payers
- Women47%
- Men52%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Michael E. Menefee wrote 261 Medicare Part D claims in 2024
In 2024, Dr. Menefee wrote 261 Medicare Part D claims for 54 patients. 90% of them were for generic drugs. CMS names the drug for 134 of them, across 4 drugs with 11 or more claims each, at $3,699 in total drug cost. In 2017, CMS named 115 claims across 7 drugs.
Part D claims, 2024261
Drugs named by CMS4
Total drug cost$3,699
Part D patients54
Dr. Menefee's Part D claims by kind of drug, 2024
- Generic234 claims90%
- Brand-name and other27 claims10%
Dr. Menefee's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Menefee's Part D claims, 2024
- Opioids7%19 of 261 claims
- Antibiotics6%15 of 261 claims
- Antipsychotics, patients 65 and over12%31 of 261 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2017 to 2024
- 2017
- 2024
- Claims for drugs CMS names
- 2017: 1152024: 13417%
Drugs named by CMS: 4 in 2024, 7 in 2017.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Michael E. Menefee offers telehealth to Medicare patients
Dr. Menefee accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Menefee as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Find medical oncologists like Dr. Menefee by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Michael E. Menefee has 14 publications on record
Dmand AI links 14 papers to Dr. Menefee, published from 2010 to 2021. 2012 was the busiest year, with 3. The most frequent topics are Thyroid Neoplasms, Antineoplastic Agents and Cell Differentiation. Dr. Menefee's most frequent co-authors are Charles Erlichman, MD, Robert Smallridge, MD and Nina J. Karlin, MD.
Papers14
Years published2010 to 2021
Dr. Menefee's papers by year, 2010 to 2021
Topics Dr. Menefee writes about most
- Thyroid Neoplasms
- Antineoplastic Agents
- Cell Differentiation
- Disease Progression
- Protein Kinase Inhibitors
Dr. Menefee's most frequent co-authors
- Charles Erlichman, MD8 shared papers
- Robert Smallridge, MD7 shared papers
- Nina J. Karlin, MD5 shared papers
Recent publications by Dr. Menefee
AnilidesCell DifferentiationDisease Progression
See who Dr. Menefee researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Menefee works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Michael E. Menefee has worked on 1 clinical trial
Dmand AI links Dr. Menefee to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Fallopian Tube Diseases and Fallopian Tube Neoplasms.
Conditions in Dr. Menefee's trials
- Fallopian Tube Diseases
- Fallopian Tube Neoplasms
Investigators on the most trials with Dr. Menefee
- Bradley Robert Corr, MD1 shared trial
- Vanessa A. Kennedy, MD1 shared trial
- Jayanthi Sivasothy Lea, MD1 shared trial
Recent clinical trials with Dr. Menefee
Fallopian Tube DiseasesFallopian Tube NeoplasmsTopotecan HydrochlorideVeliparib
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Michael E. Menefee received $12,861 in industry payments from 2016 to 2025
CMS Open Payments shows 25 general payments to Dr. Menefee from 9 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 78% of the total. Eisai Inc. paid the most, $4,928.
General payments to Dr. Menefee by program year, 2016 to 2025
General payments to Dr. Menefee by kind, 2016 to 2025
$12.9Kin total
- Consulting fees$9,99878%
- Travel and lodging$2,00916%
- Food and beverage$8557%
Companies that paid Dr. Menefee the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Michael E. Menefee graduated from Meharry Medical College School of Medicine
Dr. Menefee graduated from Meharry Medical College School of Medicine in 1999.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Michael E. Menefee's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Michael E. Menefee
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Michael E. Menefee's NPI number?
Dr. Michael E. Menefee's NPI number is 1760598601. It was assigned on August 22, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Michael E. Menefee?
Dr. Michael E. Menefee is a medical oncologist in Akron, Ohio. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Michael E. Menefee practice?
Dr. Menefee practices at 1 Akron General Avenue, Akron, OH 44307. Dr. Menefee's primary practice is Cleveland Clinic Akron General in Akron, Ohio, part of The Cleveland Clinic Foundation. Dmand AI also links Dr. Menefee to 3 hospitals.
What is Dr. Michael E. Menefee's office phone number?
The practice phone on file for Dr. Menefee is (330) 344-6000.
What is Dr. Michael E. Menefee's medical license number?
Dr. Menefee holds Ohio license 35C.000929.
Which hospitals is Dr. Michael E. Menefee affiliated with?
Dr. Menefee practices at Cleveland Clinic Akron General in Akron, Ohio. Dr. Menefee is also affiliated with Cleveland Clinic Main Campus. Dmand AI links Dr. Menefee to 3 more hospitals.
What medical group is Dr. Michael E. Menefee part of?
Dr. Menefee is linked to Cleveland Clinic.
Does Dr. Michael E. Menefee accept Medicare?
Yes. CMS data shows Dr. Menefee billed Medicare for 328 services in 2024, and Dr. Menefee accepts Medicare assignment.
Does Dr. Michael E. Menefee offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Menefee as offering telehealth services.
How many Medicare patients does Dr. Michael E. Menefee see?
CMS counts 58 Medicare patients who saw Dr. Menefee in 2024, with an average age of 75.
Show 7 more questionsShow fewer questions
What services does Dr. Michael E. Menefee bill to Medicare?
In 2024, Dr. Menefee's most billed Medicare services were medicare service (G2211), office visit, established patient (99214) and office visit, established patient (99213).
Where did Dr. Michael E. Menefee go to medical school?
Dr. Menefee graduated from Meharry Medical College School of Medicine in 1999.
What drugs does Dr. Michael E. Menefee prescribe most?
In 2024 Medicare Part D data, Dr. Menefee's most prescribed drugs by claims were Prochlorperazine Maleate, Ondansetron HCl and Olanzapine.
Has Dr. Michael E. Menefee received payments from drug or device companies?
CMS Open Payments shows $12,861 in general payments to Dr. Menefee from 9 companies from 2016 to 2025. The largest total came from Eisai Inc.
How long has Dr. Michael E. Menefee been practicing?
Dr. Menefee graduated from medical school in 1999, 27 years ago.
Does Dr. Michael E. Menefee do research?
Dmand AI links 14 publications to Dr. Menefee, published from 2010 to 2021. Dr. Menefee has worked on 1 clinical trial.
Who does Dr. Michael E. Menefee publish with?
Dr. Menefee's most frequent co-authors are Charles Erlichman, MD (8 shared papers), Robert Smallridge, MD (7 shared papers) and Nina J. Karlin, MD (5 shared papers).
Selling to medical oncology practices?
See medical oncologists in Ohio by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card